During the past decade, Hematology Oncology Associates of the Treasure Coast conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 28 clinical trials were completed, i.e. on average, 84.8% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 14 clinical trials were completed. i.e. 127.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hematology Oncology Associates of the Treasure Coast" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Bristol-Myers Squibb" with 4 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 4 trials sponsored, "Novartis Pharmaceuticals" with 4 trials sponsored and "Puma Biotechnology, Inc." with 4 trials sponsored. Other sponsors include 48 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hematology Oncology Associates of the Treasure Coast" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Hematology Oncology Associates of the Treasure Coast" are "Breast Cancer" (12 trials), "Prostate Cancer" (7 trials), "Colorectal Cancer" (5 trials), "Non-Small Cell Lung Cancer" (5 trials) and "Non-small Cell Lung Cancer" (5 trials). Many other conditions were trialed in "Hematology Oncology Associates of the Treasure Coast" in a lesser frequency.

Most popular intervention types in "Hematology Oncology Associates of the Treasure Coast" are "Drug" (72 trials), "Biological" (7 trials), "Other" (5 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Paclitaxel" (10 trials), "Carboplatin" (5 trials), "Docetaxel" (4 trials) and "Erlotinib" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hematology Oncology Associates of the Treasure Coast" are 55 trials for "All" genders, 12 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Hematology Oncology Associates of the Treasure Coast". undefined are not yet recruiting, 8 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 45 completed trials in Hematology Oncology Associates of the Treasure Coast, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Hematology Oncology Associates of the Treasure Coast, 17 "Phase 1" clinical trials were conducted, 39 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".